{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:12:14Z","timestamp":1785352334344,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Physiology Research Center","award":["92-60"],"award-info":[{"award-number":["92-60"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.cyto.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T17:20:09Z","timestamp":1462296009000},"page":"147-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease"],"prefix":"10.1016","volume":"83","author":[{"given":"A.","family":"Safa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.R.","family":"Rashidinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.04.006_b0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/biof.1024","article-title":"Inflammatory markers in coronary artery disease","volume":"38","author":"Ikonomidis","year":"2012","journal-title":"BioFactors"},{"key":"10.1016\/j.cyto.2016.04.006_b0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH07-01-0036","article-title":"The specific role of chemokines in atherosclerosis","volume":"97","author":"Braunersreuther","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cyto.2016.04.006_b0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/intimm\/dxt043","article-title":"T cells in atherosclerosis","volume":"25","author":"Tse","year":"2013","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s12265-013-9496-6","article-title":"T helper cell polarization in healthy people: implications for cardiovascular disease","volume":"6","author":"Olson","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"1","key":"10.1016\/j.cyto.2016.04.006_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.04.006_b0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/sji.12175","article-title":"On the mechanism determining the th1\/th2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases","volume":"79","author":"Bretscher","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0035","first-page":"75","article-title":"Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease","volume":"9","author":"Jafarzadeh","year":"2009","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.cyto.2016.04.006_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2008.04.009","article-title":"Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease","volume":"136","author":"de Oliveira","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2016.04.006_b0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/ATVBAHA.114.303227","article-title":"Lymphocyte migration into atherosclerotic plaque","volume":"35","author":"Li","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2016.04.006_b0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCl)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2016.04.006_b0055","doi-asserted-by":"crossref","first-page":"893106","DOI":"10.1155\/2014\/893106","article-title":"The multifaceted functions of cxcl10 in cardiovascular disease","volume":"2014","author":"van den Borne","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cyto.2016.04.006_b0060","doi-asserted-by":"crossref","first-page":"e81329","DOI":"10.1371\/journal.pone.0081329","article-title":"Cxcl10 gene promoter polymorphism-1447 A>G correlates with plasma cxcl10 levels and is associated with male susceptibility to cerebral malaria","volume":"8","author":"Wilson","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2016.04.006_b0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2009.06.006","article-title":"Genetic association between a chemokine gene CXCL10 (IP-10: interferon gamma inducible protein 10) and susceptibility to tuberculosis","volume":"406","author":"Tang","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cyto.2016.04.006_b0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2013.00194","article-title":"Cc chemokine ligand 20 and its cognate receptor CC6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil?","volume":"4","author":"Lee","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1381612820666140825122247","article-title":"Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment","volume":"21","author":"Lubberts","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cyto.2016.04.006_b0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2016.04.006_b0085","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1074\/jbc.272.9.5846","article-title":"Molecular cloning of a novel human cc chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2","volume":"272","author":"Hieshima","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2016.04.006_b0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1615\/CritRevImmunol.v22.i2.10","article-title":"Regulation of macrophage-derived chemokine (mdc, ccl22) production","volume":"22","author":"Yamashita","year":"2002","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0095","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/cncr.24255","article-title":"Genetic polymorphism in chemokine ccl22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma","volume":"115","author":"Wang","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2016.04.006_b0100","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s00296-013-2784-2","article-title":"Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus","volume":"33","author":"Tahmasebi","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cyto.2016.04.006_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2012.04.010","article-title":"Role of chemokines polymorphisms in diseases","volume":"145","author":"Guergnon","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2016.04.006_b0110","series-title":"Risk Factors for Atherosclerotic Disease in Braunwald, Text Book of Heart Disease","first-page":"1028","author":"Ridker","year":"2001"},{"key":"10.1016\/j.cyto.2016.04.006_b0115","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.cyto.2016.04.006_b0120","doi-asserted-by":"crossref","DOI":"10.3233\/CBM-160596","article-title":"Higher circulating levels of chemokine CXCL10 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism","author":"Jafarzadeh","year":"2016","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.cyto.2016.04.006_b0125","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12031-013-0214-2","article-title":"Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern","volume":"53","author":"Jafarzadeh","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cyto.2016.04.006_b0130","first-page":"45","article-title":"Investigation of the association of ccl22 gene polymorphism rs4359426 with multiple sclerosis","volume":"1","author":"Hajghani","year":"2015","journal-title":"Arch. Med. Lab. Sci."},{"key":"10.1016\/j.cyto.2016.04.006_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1152\/physiolgenomics.00104.2007","article-title":"Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease","volume":"31","author":"Ardigo","year":"2007","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.cyto.2016.04.006_b0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.ATV.0000191633.52585.14","article-title":"Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers","volume":"26","author":"Rothenbacher","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2016.04.006_b0145","doi-asserted-by":"crossref","first-page":"e21174","DOI":"10.1371\/journal.pone.0021174","article-title":"Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease","volume":"6","author":"Keeley","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2016.04.006_b0150","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0b013e31822dc7c8","article-title":"Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the prime study","volume":"77","author":"Canoui-Poitrine","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2016.04.006_b0155","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1161\/01.ATV.0000235691.84430.86","article-title":"Chemokines and incident coronary heart disease: results from the monica\/kora augsburg case-cohort study, 1984\u20132002","volume":"26","author":"Herder","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2016.04.006_b0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/cvr\/cvp391","article-title":"Chemokines in the vascular inflammatory response of atherosclerosis","volume":"86","author":"Zernecke","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cyto.2016.04.006_b0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2015.02.002","article-title":"Relationship between serum cytokine and growth factor concentrations and coronary artery disease","volume":"48","author":"Mirhafez","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cyto.2016.04.006_b0170","first-page":"677","article-title":"The selected pro- and anti-inflammatory cytokines in the patients with coronary heart disease: preliminary communication","volume":"102","author":"Mizia-Stec","year":"1999","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.cyto.2016.04.006_b0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The th17\/treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-1","article-title":"Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease","volume":"13","author":"Madhumitha","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cyto.2016.04.006_b0185","first-page":"105","article-title":"The association between infection burden in Iranian patients with acute myocardial infarction and unstable angina","volume":"43","author":"Jafarzadeh","year":"2011","journal-title":"Acta Med. Indones"},{"key":"10.1016\/j.cyto.2016.04.006_b0190","first-page":"51","article-title":"High sensitivity C-reactive protein and immunoglobulin g against chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease","volume":"5","author":"Jafarzadeh","year":"2008","journal-title":"Iran J. Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0195","doi-asserted-by":"crossref","first-page":"936109","DOI":"10.4061\/2011\/936109","article-title":"Atherosclerotic plaque stability is affected by the chemokine cxcl10 in both mice and humans","volume":"2011","author":"Segers","year":"2011","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.cyto.2016.04.006_b0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2016.04.006_b0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2014.10.088","article-title":"Treg\/th17 balance in stable cad patients with different stages of coronary atherosclerosis","volume":"238","author":"Potekhina","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2016.04.006_b0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/CRD.0000000000000006","article-title":"Inflammation in coronary artery disease","volume":"22","author":"Christodoulidis","year":"2014","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.cyto.2016.04.006_b0215","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/14017431.2010.491123","article-title":"Increased th17 cells in coronary artery disease are associated with neutrophilic inflammation","volume":"45","author":"Wang","year":"2011","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.cyto.2016.04.006_b0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.12998\/wjcc.v3.i4.345","article-title":"Atherosclerosis and the role of immune cells","volume":"3","author":"Ilhan","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.cyto.2016.04.006_b0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.atherosclerosis.2014.12.047","article-title":"Serum chemokine ccl17\/thymus activation and regulated chemokine is correlated with coronary artery diseases","volume":"238","author":"Ye","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2016.04.006_b0230","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1471-4906(00)01848-2","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"22","author":"Greaves","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0235","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.4049\/jimmunol.1200708","article-title":"Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis","volume":"191","author":"Foks","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.04.006_b0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4062\/biomolther.2010.18.2.135","article-title":"Interleukin-4, oxidative stress, vascular inflammation and atherosclerosis","volume":"18","author":"Lee","year":"2010","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.cyto.2016.04.006_b0245","first-page":"10","article-title":"Ccl22\/macrophage-derived chemokine expression in apolipoprotein E-deficient mice and effects of histamine in the setting of atherosclerosis","volume":"10","author":"Kimura","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.cyto.2016.04.006_b0250","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2014.02.005","article-title":"Allergic asthma accelerates atherosclerosis dependent on th2 and th17 in apolipoprotein e deficient mice","volume":"72","author":"Wang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cyto.2016.04.006_b0255","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/08916930902887086","article-title":"A th2 immune shift to heat shock protein 65 fails to arrest atherosclerosis: proatherogenic role of th2-deviated autoantibodies","volume":"42","author":"Xiong","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cyto.2016.04.006_b0260","first-page":"744","volume":"vol. 4","author":"Lluberas","year":"2015"},{"key":"10.1016\/j.cyto.2016.04.006_b0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7754\/Clin.Lab.2012.120225","article-title":"Plasma levels of cxcl1 (Gro-alpha) and CXCL10 (IP-10) are elevated in type 2 diabetic patients: evidence for the involvement of inflammation and angiogenesis\/angiostasis in this disease state","volume":"59","author":"Sajadi","year":"2013","journal-title":"Clin. Lab."},{"key":"10.1016\/j.cyto.2016.04.006_b0270","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.amjhyper.2004.10.034","article-title":"Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension","volume":"18","author":"Blanco","year":"2005","journal-title":"Am. J. Hypertens."},{"issue":"3","key":"10.1016\/j.cyto.2016.04.006_b0275","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10753-014-0100-2","article-title":"Simvastatin does not reduce chemokine production in obesity without comorbidities","volume":"38","author":"Fernandes","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.cyto.2016.04.006_b0280","first-page":"18082","article-title":"Comparison of cytokine expressions in acute myocardial infarction and stable angina stages of coronary artery disease","volume":"8","author":"Yan","year":"2015","journal-title":"Int. J. Clin. Exp. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T03:56:44Z","timestamp":1567828604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616300643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":56,"alternative-id":["S1043466616300643"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.04.006","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}